Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
11,898 total articles
Rajesh Vashist, Chief Executive Officer of SITIME Corp. (NASDAQ:SITM), executed a significant divestment of company shares on June 15, 2026. The executive sold a total of 20,000 shares, generating an aggregate transaction value of $15,003,000. This activity occurs as SITM shares trade at $743.14, following a substantial 253% return over the past ye…
Lam Research Corp (NASDAQ:LRCX) director Eric Brandt executed a significant divestment of company equity on June 12, 2026, selling 54,500 shares for a total value of $20,011,345. The transaction was facilitated through a Rule 10b5-1 trading plan established earlier in the year. This sale reduces Brandt’s direct holdings, which include unvested rest…
SITIME Corp director Raman Chitkara executed a transaction to sell 2,000 shares on June 12, 2026, realizing approximately $1.45 million from the disposal. The sale occurs against a backdrop of significant stock appreciation and recent positive financial reporting from the company. Chitkara retains a smaller direct stake in the corporation following…
John Gregory Cornett, serving as president of a PPL Corp subsidiary, has executed a sale of 7,051 shares of common stock. The transaction, valued at $250,733, was conducted at a price of $35.56 per share on June 12, 2026. This activity follows a 10b5-1 plan established earlier in the year, leaving Cornett with a direct holding of 7,768.93 shares in…
Enphase Energy, Inc. (NASDAQ: ENPH) Director Shanker Trivedi has increased his stake in the solar technology firm through a combination of open market purchases and restricted stock unit grants, according to recent Securities and Exchange Commission (SEC) filings. Trivedi, a former Nvidia executive who recently joined the Enphase board, acquired 1,…
Arjun Agarwal, Senior Vice President of Finance at Oruka Therapeutics, Inc. (NASDAQ: ORKA), executed a series of equity transactions in mid-June 2026, selling approximately $687,035 worth of company shares. The sales were facilitated through a pre-established Rule 10b5-1 trading plan and an automatic sell-to-cover mechanism for tax obligations. Con…
Oruka Therapeutics, Inc. (NASDAQ: ORKA) reported insider trading activity involving Chief Medical Officer Joana Goncalves on June 15, 2026. Goncalves sold 7,947 shares of common stock valued at approximately $550,606, while simultaneously acquiring 7,000 shares through the exercise of employee stock options and warrants. The transactions occurred a…
AppFolio Inc. (NASDAQ: APPF) General Counsel Evan Pickering executed a series of stock sales totaling $102,461 on June 12, 2026, according to an SEC Form 4 filing. The transaction involved the disposal of 660 shares across multiple price tiers, leaving Pickering with a direct holding of 6,555 shares. This insider activity occurs against a backdrop …
Timothy Mathias Eaton, Chief Financial Officer at AppFolio Inc. (NASDAQ: APPF), completed a series of stock transactions on June 12, 2026, resulting in the sale of shares valued at $413,787. The divestitures were executed under a Rule 10b5-1 trading plan, with prices spanning from $154.66 to $161.83 per share. Following the transactions, Eaton reta…
Don Rigler, the principal accounting officer at AppFolio Inc., executed a sale of 150 shares of the company's Class A Common Stock on June 12, 2026. The transaction, valued at $23,934, was completed at a weighted average price of $159.56 per share, with individual sale prices ranging between $159.56 and $160.55. Following this disposal, Rigler reta…
Regency Centers Corporation (NASDAQ: REG) reported robust first-quarter financial performance, surpassing analyst expectations for both earnings and revenue. Concurrently, internal corporate activity was observed as Principal Accounting Officer Devereaux Terah L executed multiple share dispositions. The company also maintained its shareholder retur…
Alexandra M. Luster, Senior Vice President and General Counsel at Lincoln Educational Services Corp. (NASDAQ: LINC), executed a sale of 18,007 shares of the company's common stock on June 15, 2026. The transaction, which generated proceeds totaling $803,832, was conducted through multiple open-market trades priced between $44.31 and $44.80 per shar…
Oruka Therapeutics, Inc. (NASDAQ: ORKA) reported a recent equity transaction involving its General Counsel, Paul T. Quinlan, who sold shares to satisfy tax obligations. This administrative move occurs against a backdrop of significant corporate developments for the company, including a major capital raise and positive clinical data from its ORKA-00…
Laura Lee Sandler, Chief Operating Officer at Oruka Therapeutics, Inc. (NASDAQ: ORKA), completed a sale of 600 common shares on June 15, 2026, valued at $41,814. The transaction was processed through the company's automatic, non-discretionary sell-to-cover procedure to fulfill tax withholding requirements linked to vesting restricted stock units. P…
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) director Corazon D. Sanders executed a sale of 2,000 shares on June 15, 2026, realizing proceeds of $50,100 at an average price of $25.05 per share. The transaction reduces her direct holdings to 21,095 shares, including those tied to Restricted Stock Units under vesting schedules. This insider activity …
Meredith Cook, serving as Senior Vice President, General Counsel, and Secretary at ANI Pharmaceuticals Inc. (NASDAQ:ANIP), executed a sale of company stock on June 12, 2026. The transaction involved the disposal of 500 shares at a unit price of $82.03, resulting in total proceeds of $41,015. This activity occurs within the context of a robust finan…
Cadence Design Systems Inc. (CDNS) director James D. Plummer executed a sale of company stock totaling $576,204 on June 11, 2026, according to Securities and Exchange Commission records. The transaction involved 1,511 shares priced at $381.34 per share, conducted under a pre-established Rule 10b5-1 trading plan adopted in March 2026. Following the …
Lyell Immunopharma (NASDAQ:LYEL) VP Veronica Sanchez Bulis executed a sale of 217 common shares on May 11, 2026, totaling $4,103. The transaction, priced between $18.91 and $19.30 per share with a weighted average of $18.91, was triggered by automatic sales to meet tax withholding obligations from vested restricted stock units. Post-transaction, Bu…
Accel Entertainment Inc. (NASDAQ: ACEL) Chief Operating Officer Mark T. Phelan executed a structured sale of 25,000 shares on June 15, 2026, totaling $325,000. The transaction occurred at $13.00 per share, leaving Phelan with a direct holding of 241,464 shares. The sale was facilitated by a Rule 10b5-1 trading plan adopted in March 2026, which incl…
Lyell Immunopharma, Inc. (NASDAQ: LYEL) reported a recent insider transaction involving Chief Scientific Officer Gary K. Lee. The sale was executed to satisfy tax withholding requirements following the vesting of restricted stock units. This financial activity occurs against a backdrop of ongoing clinical developments and shifting analyst sentiment…
Lyell Immunopharma, Inc. (NASDAQ: LYEL) President and Chief Executive Officer Lynn Seely sold 388 shares of common stock on May 11, 2026. The automatic transaction, totaling $7,337, was executed to cover tax withholding obligations from the settlement of vested restricted stock units. Following the sale, Ms. Seely retains direct ownership of 73,878…
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Chief Operating Officer Stephen J. Hill executed a sale of 89 shares on May 11, 2026, to satisfy tax withholding obligations from vested restricted stock units. The transaction, valued at $1,683, occurred at a weighted average price of $18.92 per share, significantly above the stock's recent trading range of $…
Derek Harmer, Chief Compliance Officer at Accel Entertainment, Inc. (NASDAQ:ACEL), executed a sale of 20,000 shares of the company’s Class A-1 Common Stock on June 15, 2026, totaling $260,000. The transaction, priced at $13.0 per share, was conducted under a Rule 10b5-1 trading plan adopted on December 13, 2024, with Harmer confirming at that time …
David R. Gerken, Executive Vice President at Farmers & Merchants Bancorp Inc. (NASDAQ:FMAO), executed a sale of 825 shares of the company’s common stock on June 11, 2026. The transaction was valued at $23,232, with each share sold at $28.16. Post-transaction, Gerken retains direct ownership of 7,509 shares. Concurrently, FMAO announced a 4% increas…
Phillip P. Chan, Chief Executive Officer and a director at Cytosorbents Corp (NASDAQ:CTSO), has completed open market purchases totaling $104,897 in the company's common stock. The acquisitions took place on June 12 and June 15, 2026, with the executive buying shares at prices between $0.40 and $0.43. This insider activity occurs against a backdrop…
